Experts are asking whether the study and treatment of myeloproliferative neoplasms (MPNs) is ready for a new era with new end ...

According to research conducted recently on over 200 members of the scientific society, in the face of the whirlwind and ...

There can be a delay in diagnosis of myeloproliferative neoplasms as the symptoms of the diseases can be variable and common, ...

Explore iEUS, a deep-learning method that improves the detection of pancreatic neuroendocrine neoplasms through endoscopic ...

The World Health Organization reports that roughly 2.3 million women were diagnosed with breast cancer in 2020. By the end of ...

NEW HAVEN, Conn., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces the launch of a new version of its Bloodhound MPN (Myeloproliferative ...

Lung cancer (LC) continues to represent the second most common neoplasm in both sexes and the leading cause of cancer-related mortality, with approximately 1.8 million deaths in 2022. 70% of patients ...

While adenoma was detected at lower rates in the younger group (59% vs 67%; RR 0.88, 95% CI 0.83-0.95), there were similar ...

Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the United States (U.S.) Food and Drug ...

There isn’t a single answer to what causes pancreatic cancer because it involves multiple factors. Here’s what science knows ...

Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the United States (U.S.) Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for TLX101-CDx ...

Multiple myeloma is a type of blood cancer originating in the plasma cell, known as a plasma cell neoplasm (PCN), and though sensitive and accurate identification of genetic abnormalities in MM ...